![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 06, 2021 4:03:00 AM
I was doubting after all the stories of Dr. J and Dr. Ram that RELIEF is ready to perform a filing act on their own ! The process of EUA/NDA of Zyesami has been so much driven by JJ - I was somewhat getting this impression. (Sorry RLF, I still love you).
Now today seeing RLF to perform a successful FDA filing is very relevant since you see that this company is able to perform this very demanding procedure.
An accepted file for NDA needs many details, starts with preclinical data, toxicology in mice, GMP production details, goes to package insert writing (very relevant) to human phase III data presentation, labeling, supply chain and a postmarketing plan etc.
Now I see that RLF is very capable, even better FDA proven to be capable, to perform such an act.
This is very reassuring and shows to me that RLF can act on its own as independent pharma company !
They have everything in place to advance to Big Pharma!
~ IG, Y@h00 RLFTF finance conversations
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM